However, the expression levels of KRT80, FABP6, FOXQ1, and GAS2 mRNAs (Supplementary Figure S2A–F) were not significantly associated with the clinical outcomes of CRC patients. This evidence concerns the gene GAS2 and colorectal carcinoma.